Literature DB >> 3526268

Fungal colonization in the very low birth weight infant.

J E Baley, R M Kliegman, B Boxerbaum, A A Fanaroff.   

Abstract

In the neonate, fungal infections result in significant morbidity and mortality. For very low birth weight (less than 1,500 g) infants, we prospectively determined the fungal colonization rate to be 26.7%. In one third of infants with fungal colonies, mucocutaneous candidiasis developed, and in 7.7%, systemic disease developed. Two thirds of the infants had colonies in the first week of life. This colonization was probably acquired during labor and delivery, because those infants who had colonization were more often delivered vaginally than by cesarean section. Early colonization, commonly from the gastrointestinal or respiratory tract, featured Candida albicans and Candida tropicalis. Late colonization, occurring after 2 weeks of life (15.0% of patients), was more likely to be cutaneous and was associated with either Candida parapsilosis or such poor growth that the organism could not be identified. Infants with colonization only rarely had budding yeasts (6.1%), whereas more than half of the infants with either a urinalysis showing budding yeasts or a urine culture growing fungi had invasive disease. Fungal contamination was not found on either thoracotomy tubes or catheter tips. In the low birth weight infant, fungal colonization represents a significant risk factor for cutaneous or systemic candidiasis in these infants.

Entities:  

Mesh:

Year:  1986        PMID: 3526268

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  Prevalence and immediate outcome of candida colonized preterm neonates admitted to Special Care Unit of Mulago Hospital, Kampala Uganda.

Authors:  Yaser Abdallah; Deogratias Kaddu-Mulindwa; Jolly Nankunda; Philippa M Musoke
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study.

Authors:  Ruchika Mohan; Corinna Koebnick; Janko Schildt; Sabine Schmidt; Manfred Mueller; Mike Possner; Michael Radke; Michael Blaut
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

4.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

Review 5.  Gowns, caps and masks in neonatal units: are they necessary?

Authors:  T N Raju
Journal:  Indian J Pediatr       Date:  1988 Sep-Oct       Impact factor: 1.967

6.  Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study.

Authors:  S E Reef; B A Lasker; D S Butcher; M M McNeil; R Pruitt; H Keyserling; W R Jarvis
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Molecular epidemiology of Candida albicans colonization and fungemia in very low birthweight infants.

Authors:  J L Robinson; A I Hartstein; R U Meuser; V H Morthland; M E Dragoon; W M Wenman
Journal:  Can J Infect Dis       Date:  1993-11

Review 8.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Authors:  Emmanuel Roilides; Evangelia Farmaki; Joanna Evdoridou; Andrea Francesconi; Miki Kasai; Joanna Filioti; Maria Tsivitanidou; Danai Sofianou; George Kremenopoulos; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 10.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.